NTLA
Price
$26.17
Change
-$0.05 (-0.19%)
Updated
May 16, 6:59 PM EST
77 days until earnings call
OABI
Price
$4.54
Change
-$0.00 (-0.00%)
Updated
May 16, 6:59 PM EST
Ad is loading...

NTLA vs OABI

Header iconNTLA vs OABI Comparison
Open Charts NTLA vs OABIBanner chart's image
Intellia Therapeutics
Price$26.17
Change-$0.05 (-0.19%)
Volume$812.46K
CapitalizationN/A
OmniAb
Price$4.54
Change-$0.00 (-0.00%)
Volume$253.6K
CapitalizationN/A
View a ticker or compare two or three
NTLA vs OABI Comparison Chart

Loading...

NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
OABIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
NTLA vs. OABI commentary
May 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Hold and OABI is a Hold.

COMPARISON
Comparison
May 17, 2024
Stock price -- (NTLA: $26.22 vs. OABI: $4.54)
Brand notoriety: NTLA and OABI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 105% vs. OABI: 78%
Market capitalization -- NTLA: $2.53B vs. OABI: $533.97M
NTLA [@Biotechnology] is valued at $2.53B. OABI’s [@Biotechnology] market capitalization is $533.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $592.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 0 FA rating(s) are green whileOABI’s FA Score has 1 green FA rating(s).

  • NTLA’s FA Score: 0 green, 5 red.
  • OABI’s FA Score: 1 green, 4 red.
According to our system of comparison, both NTLA and OABI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 5 TA indicator(s) are bullish while OABI’s TA Score has 5 bullish TA indicator(s).

  • NTLA’s TA Score: 5 bullish, 4 bearish.
  • OABI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, OABI is a better buy in the short-term than NTLA.

Price Growth

NTLA (@Biotechnology) experienced а +14.00% price change this week, while OABI (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +4.69%, and the average quarterly price growth was +62.76%.

Reported Earning Dates

NTLA is expected to report earnings on Aug 01, 2024.

OABI is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for NTLA with price predictions.
OPEN
A.I.dvisor published
a Summary for OABI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NTLA($2.48B) has a higher market cap than OABI($529M). NTLA YTD gains are higher at: -14.005 vs. OABI (-26.418).
NTLAOABINTLA / OABI
Capitalization2.48B529M469%
EBITDAN/AN/A-
Gain YTD-14.005-26.41853%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLAOABI
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
54%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
43%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
41%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
47%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
63%
Declines
ODDS (%)
Bearish Trend 22 days ago
84%
Bearish Trend 9 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 4 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
OABIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACFOX56.130.75
+1.35%
American Century Focused Dynamic Gr Inv
LQFLX12.460.12
+0.97%
Lord Abbett Focused Large Cap Value R3
ESMAX16.040.15
+0.94%
Invesco EQV Euro Small Company A
AVEFX11.930.03
+0.25%
Ave Maria Bond
PLFSX25.91N/A
N/A
Principal Large Cap S&P 500 Index R4

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with BEAM. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+1.90%
BEAM - NTLA
76%
Closely correlated
+1.26%
EDIT - NTLA
70%
Closely correlated
+5.63%
VCYT - NTLA
69%
Closely correlated
+2.30%
PRME - NTLA
64%
Loosely correlated
+1.50%
DNLI - NTLA
63%
Loosely correlated
+5.62%
More

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with ABCL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
+0.89%
ABCL - OABI
43%
Loosely correlated
-3.14%
NTLA - OABI
40%
Loosely correlated
+1.90%
LGND - OABI
39%
Loosely correlated
+0.56%
TFFP - OABI
38%
Loosely correlated
+8.06%
DNLI - OABI
38%
Loosely correlated
+5.62%
More